Agilon Health AGL Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $211.57M+21.8% | $173.71M+1.2% | $171.68M+0.2% | $171.42M+23.7% | $138.62M-28.5% | ||
| $899.75M+33.5% | $673.79M-28.9% | $947.16M-9.6% | $1.05B-15.5% | $1.24B+21.9% | ||
| $1.32B+20.5% | $1.1B-18.0% | $1.34B-7.9% | $1.45B-12.0% | $1.65B+13.2% | ||
| $24.89M-2.1% | $25.42M-2.8% | $26.15M-4.6% | $27.41M-2.4% | $28.09M-0.3% | ||
| $62.45M-5.0% | $65.73M-12.7% | $75.25M+14.7% | $65.6M-3.8% | $68.19M-6.3% | ||
| $1.5B+18.4% | $1.27B-20.4% | $1.6B-6.8% | $1.71B-11.4% | $1.93B+11.5% | ||
| $202.48M+58.8% | $127.48M-12.4% | $145.52M-15.3% | $171.89M-24.2% | $226.69M+2.9% | ||
| $14.75M-23.3% | $19.24M-45.0% | $34.97M— | —— | —— | ||
| $1.27B+18.2% | $1.08B-13.2% | $1.24B-0.7% | $1.25B-9.1% | $1.37B+19.3% | ||
| $15.28M-3.0% | $15.75M— | $0— | $0— | $0-100% | ||
| $1.32B+15.6% | $1.14B-11.3% | $1.29B-1.1% | $1.3B-9.0% | $1.43B+13.4% | ||
| 2B0.0% | 2B0.0% | 2B0.0% | 2B0.0% | 2B+48,420% | ||
| -$1.93B+2.5% | -$1.98B-10.6% | -$1.79B-6.6% | -$1.68B-6.6% | -$1.57B+0.8% | ||
| $181.43M+43.2% | $126.73M-58.6% | $306.08M-25.2% | $408.93M-18.3% | $500.25M+6.2% | ||
| $1.5B+18.4% | $1.27B-20.4% | $1.6B-6.8% | $1.71B-11.4% | $1.93B+11.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Agilon Health cover its short-term obligations?
- Its current ratio is 1.04 — current assets exceed current liabilities.
- Where does Agilon Health's balance sheet data come from?
- Every line is extracted from Agilon Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.